Thomas Foltynie and London - Free people check

(1 - 11 from 13

)

Axovant's Parkinson's Disease Gene Therapy Clinical Trial Launched in...

www.labiotech.eu

A gene therapy for Parkinson's disease developed by Swiss biotech Axovant has been used on the first patient in a Phase I/II trial at University College London.

Diabetes drug tested in Parkinson's disease patients

medicalxpress.com

In this issue of the Journal of Clinical Investigation, Dr. Thomas Foltynie and colleagues at the National Hospital for Neurology and Neurosurgery in London ...

Exenatide Has Potential as a Disease Modifying Agent in Parkinson’s...

www.iospress.com

... senior investigator Thomas Foltynie, MRCP, PhD, of the Sobell Department of Motor Neuroscience, UCL Institute of Neurology, London, UK.

Prof T. Foltynie | UCL Queen Square Institute of Neurology - UCL –...

www.ucl.ac.uk

Prof. Thomas Foltynie BSc, MBBS, MRCP, PhD. Professor Tom Foltynie is Professor of Neurology in the Department of Clinical and Movement Neurosciences, UCL Institute of Neurology and Consultant Neurologist at the National Hospital for Neurology and Neurosurgery, Queen Square, London. He is responsible for Movement disorder patients, particularly ...

Diabetes drug tested in Parkinson's disease p | EurekAlert!

www.eurekalert.org

In this issue of the Journal of Clinical Investigation, Dr. Thomas Foltynie and colleagues at the National Hospital for Neurology and Neurosurgery in London...

ALZFORUM | NETWORKING FOR A CURE

www.alzforum.org

· Thomas Foltynie, MBBS MRCP PhD. UCL Institute of Neurology. Contact Information. Thomas Foltynie, MBBS MRCP PhD London, United Kingdom

Thomas Foltynie, PhD, MD, MRCP | Parkinson's Disease

www.michaeljfox.org

Thomas Foltynie, PhD, MD, MRCP, is an academic neurologist at the National Hospital for Neurology and Neurosurgery and the University College London (UCL) Institute of Neurology. He trained in medicine at UCL then undertook his PhD and his neurology training at the University of Cambridge, with a thesis entitled “The Incidence and Heterogeneity of Parkinson’s Disease in Cambridgeshire.”

Exenatide Treatment Alleviated Symptoms of Depression in Patients...

www.journalofparkinsonsdisease.com

· “In the original analysis of the exenatide-PD trial, the primary outcome was a comparison in the motor severity of PD,” explained Thomas Foltynie, PhD, MBBS, Sobell Department of Motor Neuroscience, UCL Institute of Neurology, and The National Hospital for Neurology and Neurosurgery, London, UK, who led the exenatide trial and is lead ...

Foltynie – The Science of Parkinson's

scienceofparkinsons.com

· This is a tremendous result for Prof Thomas Foltynie and his team at University College London Institute of Neurology, and for the Michael J Fox Foundation for Parkinson’s Research who funded the trial. Not only do the results lay down the foundations for a novel range of future treatments for Parkinson’s disease, but they also validate the ...

Deep Brain Stimulation for Patients With Dementia With Lewy Bodies -...

clinicaltrials.gov

Thomas Foltynie, MB BS MRCP: UCL Institute of Neurology: More Information. No publications provided . Responsible Party: University College, London:

All web results to the name "Thomas Foltynie"

Related search requests for Thomas Foltynie

Patricia Limousin
Carol Brayne

People
Forename "Thomas" (109888)
Name "Foltynie" (1)

sorted by relevance / date

Advanced Search

Search name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Thomas Foltynie and London Free People Check